Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Invitation to Apotea's Q2 2025 webcast

Apotea

Apotea AB (publ) ("Apotea") will publish its Q2 2025 report at 07:30 am CEST on Friday the 18th of July. Investors, analysts, media and other interested parties are welcome to join a webcast and presentation of the interim report at 09:30 am the same day. 

The results for the period January - June 2025 will be presented by Pär Svärdson, CEO and Johan Mårild, CFO via a webcast held on 18th of July 2025 at 09:30 am.

Link for webcast participation (no advance notification is necessary): https://apotea.events.inderes.com/q2-report-2025   

If you wish to participate via teleconference, please register on the link below: https://events.inderes.com/apotea/q2-report-2025/dial-in

The presentation will be held in English.

For further information, please contact:
Stefan Eriksson, deputy CEO & Investor Relations

E-mail: ir@apotea.se

About Apotea
Apotea is Sweden's leading online pharmacy by market share with the goal of becoming the largest pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low prices and quick deliveries, Apotea facilitates everyday life for its three million active customers. In E-barometern's 2024 customer survey, Apotea was ranked as customers' favourite e-commerce store for the seventh consecutive year. Since 2022, the group also operates in Norway through its Norwegian subsidiary Apotera.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.